Search results
SRS, WBRT, and the combination of SRS plus WBRT are all reasonable options for patients with more than four unresected or more than two resected brain metastases and better performance status (eg, KPS ≥ 70).
- Survival in Patients With Brain Metastases: Summary Report on the ...
Methods. A multi-institutional database of 6,984 patients...
- Survival in Patients With Brain Metastases: Summary Report on the ...
ICD 10 code for Secondary malignant neoplasm of brain. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code C79.31.
15 wrz 2020 · Methods. A multi-institutional database of 6,984 patients with newly diagnosed brain metastases underwent multivariable analyses of prognostic factors and treatments associated with survival for each primary site. Significant factors were used to define the updated GPA. GPAs of 4.0 and 0.0 correlate with the best and worst prognoses, respectively.
3 kwi 2023 · Objectives: Describe the pathophysiology of brain metastases. Review the evaluation of a patient with brain metastases. Summarize the treatment options for brain metastases. Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by brain metastases.
Tsao et al 11 concluded that “multiple brain metastases and good prognosis (expected survival 3 months or more): for selected patients with multiple brain metastases (all less than 3 to 4 cm), radiosurgery alone, WBRT and radiosurgery, or WBRT alone should be considered, based on level 1 evidence.
This article provides a review of the epidemiology, pathology, diagnosis, and treatment of brain metastases and the corresponding supporting evidence. Keywords: metastasis, radiosurgery, laser interstitial thermal therapy (LITT), craniotomy, immunotherapy, whole brain radiotherapy (WBRT), SRS.
23 lis 2022 · Introduction. Brain metastases (BM) affect up to one-third of adults with solid tumor malignancies and are associated with significant cancer patient morbidity, anxiety, and mortality. Approximately 70,000–400,000 patients will develop BM each year in the USA [1, 2, 3].
